Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Balance as of beginning of period (in shares) at Dec. 31, 2023   7,502,478      
Balance as of beginning of period at Dec. 31, 2023 $ 68,340 $ 2 $ 425,471 $ (96) $ (357,037)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares) 46,000 93,874      
Issuance of common stock upon exercise of stock options and release of restricted stock units $ 285   285    
Stock-based compensation 5,087   5,087    
Net loss (28,314)       (28,314)
Other comprehensive income 52     52  
Balance as of end of period (in shares) at Mar. 31, 2024   7,596,352      
Balance as of end of period at Mar. 31, 2024 45,450 $ 2 430,843 (44) (385,351)
Balance as of beginning of period (in shares) at Dec. 31, 2024   194,909,430      
Balance as of beginning of period at Dec. 31, 2024 $ 39,664 $ 4 469,994 0 (430,334)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares) 0 470,953      
Stock-based compensation $ 4,074   4,074    
Issuance of common stock in connection with warrant cancellation, (in shares)   14,852,379      
Issuance of common stock in connection with warrant cancellation 14,555   14,555    
Net loss (25,411)       (25,411)
Balance as of end of period (in shares) at Mar. 31, 2025   210,232,762      
Balance as of end of period at Mar. 31, 2025 $ 32,882 $ 4 $ 488,623 $ 0 $ (455,745)